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Introduction
A 9-year-old female patient presented with cyano-
sis due to an intra-pulmonary right to left shunt.
Imaging and biopsy showed congenital absence of
the portal vein, interruption of the inferior vena
cava and focal nodular hyperplasia in the liver. The
authors believe this is the first reported case of end-
to-end shunting of portal blood into the inferior
vena cava and the second case of congenital
absence of the portal vein causing hepatopulmon-
ary syndrome. The imaging findings are described
and the literature reviewed.
Case report
A 9-year-old female patient presented to the accident and
emergency department with dry cough and decreased exercise
tolerance. Obstetric and perinatal history was uneventful and
she enjoyed good health in the past. No significant family history
noted. Oxygen saturation (SaO2) was 90% on room air. Physical
examination revealed central cyanosis. Blood gas investigation
showed PaO2 of 62 mmHg, which did not improve significantly
after 50% oxygen. Contrast echocardiogram using agitated
normal saline confirmed intra-pulmonary shunting. No cardiac
abnormality detected by echocardiogram. Blood ammonia level
was normal and there was no sign of hepatic encephalopathy.
Chest radiograph was unremarkable apart from a prominent
azygos vein. Computed tomography (CT) of the thorax and
abdomen (Lightspeed QX/i Four-slice scanner, General Electric
Medical Systems, Milwaukee, WI, USA) revealed no macroscopic
arteriovenous malformation in the thorax but the pulmonary
vessels were prominent. The intra-hepatic portal veins were
absent with hypertrophy of the hepatic arteries, compatible with
congenital absence of the portal vein (CAPV) (Fig. 1). The infra-
hepatic portion of the inferior vena cava (IVC) was totally absent
(Fig. 2). The right common iliac vein and right renal vein drained
into the azygos vein. On the other side, the left common iliac
vein and left renal vein drained into the hemiazygos vein. The
hemiazygos system finally drained into the azygos vein in the
thorax. The superior mesenteric vein (SMV) joined with the
splenic vein and drained directly into the IVC behind the liver in
an end-to-end manner. A 4 cm nodule was noted in segment 2 of
the liver (Fig. 3). The situs of the internal organs was normal. CT-
guided core biopsy of the nodule and adjacent liver parenchyma
showed absence of portal venous branches and focal nodular
hyperplasia (FNH). No evidence of chronic liver disease noted.
Discussion
Although variants or partial agenesis of the portal
system are not uncommon,1 congenital total
absence of the intra-hepatic portal veins is a rare
malformation, and was first described by John
Abernethy in 1793.2 Howard and Davenport3 used
the term “Abernethy malformation” to describe
patients with congenital diversion of portal blood
away from the liver, either by end-to-side or side-
to-side extra-hepatic shunt. Morgan and Superina4
have classified portosystemic shunts into two types
with emphasis on functional and clinical differ-
ences. In type 1 shunts, the liver is not perfused
with portal blood and is equivalent to CAPV. Type 1
shunts are further classified into type 1a where the
SMV and splenic vein do not join to form confluence
and type 1b where the two veins join before
entering the systemic circulation. Type 2 shunts
are partial shunts due to portal-hepatic anasto-
moses. The actual prevalence of CAPV is not known
as some patients are asymptomatic and only
detected incidentally. To date 37 cases of CAPV
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are reported in the English literature. The age at
diagnosis varies between 1 day and 50 years, most
cases being diagnosed in childhood. Most reported
cases were female. Various routes of drainage of
the portal blood are described in the literature,
including entrance into the supra- or infra-hepatic
IVC, left-side IVC, left hepatic vein, left renal vein,
left iliac vein or through collaterals to the azygos
system. Liver anomalies are very common and
include liver dysfunction, FNH,5–7 nodular regen-
erative hyperplasia, hepatic adenoma, hepatoblas-
toma, hepatocellular carcinoma and biliary atresia.
Other frequently associated congenital abnormal-
ities include cardiovascular and situs anomalies,
polysplenia, Goldenhar syndrome and IVC
abnormalities.
Figure 1 Transverse CT images of the upper abdomen
after intravenous contrast medium administration. (a)
The intra-hepatic branches of the portal vein are totally
absent. Atretic remnants of the proximal portion of the
main right and left portal branches are noted (arrow). (b)
The intra-hepatic branches of the hepatic arteries have
hypertrophied.
Figure 2 Transverse CT images after intravenous con-
trast medium administration. (a) At the level of the
confluence of the splenic vein and the superior mesentery
vein. The IVC is absent. The retrocrural azygos vein
(arrow) and hemiazygos vein (arrowhead) are grossly
distended because they drain the blood from the lower
part of the body as a result of inferior vena cava
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The relationship between CAPV and nodular
hyperplasia has been reviewed by Motoori et al.8
It is still uncertain whether circulatory disturbance
alone in the liver could cause nodular hyperplasia or
not. Nevertheless the association between disturb-
ance of portal blood flow and nodular hyperplasia of
the liver appears to be very strong.9–11
Hepatic encephalopathy is a common presen-
tation in patients with portal-systemic shunt.
Watanabe12 reviewed the causes of porto-systemic
encephalopathy in non-cirrhotic patients and
included CAPV as type V cause. Our patient
presented with hepatopulmonary syndrome instead
of encephalopathy, which is the second case
reported in patients with CAPV.13 Hepatopulmonary
syndrome is the clinical relationship between
hepatic disease and the existence of pulmonary
vascular dilatations, which can result in a range of
arterial oxygenation abnormalities. The question of
why some patients had encephalopathy, a few had
hepatopulmonary syndrome and others were
asymptomatic is difficult to answer. To date no
patient with CAPV and both hepatic encephalo-
pathy and hepatopulmonary syndrome has been
reported. As the number of patients with a
congenital portosystemic shunt presenting as hepa-
tic encephalopathy is larger, its pathogenesis and
prognosis are better studied in the literature.12,14,15
Very little is known about the pathogenesis of
hepatopulmonary syndrome in patients with CAPV.
Intra-pulmonary vascular dilatations due to altera-
tion in the synthesis or metabolism of vasoactive
pulmonary substances at the hepatic level have
been suggested as the cause of hepatopulmonary
syndrome in patients with end-stage liver parench-
ymal disease complicated by portosystemic shunt.
Whether this mechanism can be applied to patients
with CAPV is uncertain.
A review by Mayo et al.16 indicates anomalies of
the IVC are not rare. Anderson et al.17 in 1961
suggested the use of “infra-hepatic interruption of
the IVC with azygos (hemiazygos) continuation” to
describe the condition of failure of fusion of the
hepatic and prerenal segments of the IVC combined
with persistence of either the right lumbar azygos
vein or the left lumbar hemiazygos vein.17 This
interruption. (b) At mid-heart level the azygos vein
(arrow) is as big as the descending aorta, the basis of
the “double vessels” sign for the prenatal sonographic
diagnosis of interruption of inferior vena cava. Note the
prominent descending branches of the pulmonary arteries
on both sides, probably related to the intra-pulmonary
shunting. (c) At the level of the azygos arch, which is
grossly dilated. The azygos vein drains into the superior
vena cava as usual (arrow).
Figure 3 Transverse CT images in the upper abdomen,
before and after contrast medium administration. A 4 cm
nodule was noted in segment 2 of the liver. (a) It is
isodense in the non-contrast study, (b) hyperdense in the
arterial phase and (c) hypodense in the portal venous
phase. Small central scar, which is hypodense in the
arterial phase and hyperdense in the portal venous phase,
was noted within the nodule.
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group of patients was first described by Stark in
183518 and later by Dwight in 1900.19 It is often
associated with cardiosplenic syndromes.17,20 The
present patient represented a rare form of inter-
ruption of IVC, in which there are bilateral inferior
venae cavae draining into the azygos and hemi-
azygos systems respectively, similar to a case
described by Mayo et al.16
Although embryologically the systemic veins in
the abdomen are described as intra-embryonic
while the portal venous system as extra-embryonic,
they are intimately related both in spatial relation-
ship and in temporal development, especially at the
region of the developing liver. Anastomoses are
present between the two systems during early
development of the embryo.
The development of the portal vein occurs
between 4–10 weeks gestation, by selective
regression of peri-intestinal vitelline venous loops.
Abnormal involution of the vitelline veins can lead
to malformations such as preduodenal portal vein.
Conversely CAPV can be the result of excessive
regression of the venous plexus in the vicinity of the
developing liver.
The development of the IVC is even more
complex and occurs between 6–8 weeks gestation.
It also involves progressive development and
regression of vessels, namely the paired posterior
cardinal, subcardinal and supracardinal systems.16
Mayo et al. suggested that bilateral IVC with azygos
and hemiazygos continuation represents persist-
ence of the entire supracardinal system, without
evidence of right-sided dominance.
The association of portal vein anomalies with IVC
abnormalities is not rare. The presence of pre-
duodenal portal vein and abnormality of the IVC is
well documented.21 The patient reported by
Howard and Davenport had both absence of the
portal vein and interruption of the IVC with azygos
continuation. However, her preduodenal portal
vein drained into the azygos vein and she had
other congenital abnormalities including situs
inversus, polysplenia and biliary atresia.3 The
authors postulated that the complicated develop-
ment of IVC and its close relationship with the
development of the vitelline veins might explain
the occurrence of this association. Le Borgne et al.22
reported a 64-year-old woman having interruption
of the IVC with azygos continuation associated with
CAPV. However, the drainage of the portal blood
was rather complex in this patient. She remained
asymptomatic and these anomalies were only
detected incidentally during an operation for
cholangitis due to lithiasis. Le Borgne et al. stressed
the possible role of the haemodynamic thrust of the
flow of the left umbilical vein in the pathogenesis of
these double interruptions. Another example of
developmental abnormality involving both systems
was a patient who had infra-hepatic interruption of
the IVC with portal continuation.23 As in many other
disorders, corresponding animal examples are also
well documented in the literature, especially in
dogs where two cases of congenital interruptions of
portal vein and caudal vena cava were reported.24
In view of this particular combination, the
present patient represents the first reported case
of end-to-end portosystemic shunt in Abernethy
malformation. It is of interest that both conditions
are commonly associated with other congenital
cardiovascular, splenic and situs anomalies, but
none occurred in the present patient.
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